May 15, 2024 | ASTRO News The Radiation Oncology Case Rate (ROCR) Value-Based Payment Program Act would improve access, enhance quality and reduce disparities in American cancer care. Today marks a significant milestone in cancer care with the introduction of...
Press Releases & Articles
Xcision to feature GammaPod – a powerful tool for breast cancer – at ESTRO 2024
COLUMBIA, Md. - Xcision Medical Systems, LLC, a medical technology company that develops advanced stereotactic radiotherapy solutions to improve cancer care, will demonstrate GammaPod at The European Society for Radiotherapy and Oncology (ESTRO) on May 3-7 in Glasgow,...
Minimizing Treatment Fractions for Early-Stage Breast Cancer Patients
April 24, 2024 | Xcision Article Missed Xcision’s webinar on how to reduce radiation toxicity by reducing the treatment to a single fraction? In this clinical education webcast, Dr. Marco Trovò from Azienda sanitaria universitaria Friuli Centrale (ASU FC) in Udine,...
No Pain, No Anesthesia, No Scars: The Driving Idea to Develop GammaPod
Cedric Yu, GammaPod inventor and founder of Xcision Medical Systems, LLC, talks about how an idea to create a more convenient radiotherapy technology came about—and how the GammaPod is now available to women with breast cancer. The idea of a better radiation treatment...
Xcision to feature GammaPod™ at Arab Health 2024
COLUMBIA, Md., January 27, 2024 Xcision to feature GammaPod™ at Arab Health 2024 GammaPod provides new treatment options for breast cancer patients Xcision Medical Systems, LLC, a medical technology company developing advanced stereotactic radiotherapy solutions to...
Medicare physician payment final rule cements more cuts to radiation oncology, underscores need for legislative fix
November 2, 2023 | ASTRO News The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M. Michalski, MD, MBA, FASTRO, Chair of the ASTRO Board of Directors, in response to the final 2024 Medicare Physician Fee Schedule...
World’s Largest Medtech Accelerator Announces 61 Startups for its 2023 Cohort
“The 2023 MedTech Innovator Cohort once again includes passionate medtech entrepreneurs from around the globe. We look forward to working with our corporate partners and industry advisors over the course of the program, to help these startups advance their medical...
Hundred treatments carried out and completed with GammaPod in Udine, Italy
It’s been one year since the press conference which set off the clinical use of GammaPod in Udine. A year of intense work for the staff of the ASUFC Radiotherapy department, which led to the successful completion of the hundredth stereotactic radiotherapy breast...
Xcision Announces Start of Breast Cancer Treatments Using GammaPod™ Stereotactic Radiotherapy System at Leading Italian Hospital
COLUMBIA, Md. (PRWEB) April 12, 2022 Xcision Medical Systems, LLC today announced that Azienda Sanitaria Universitaria Friuli Centrale (ASU FC) in Italy recently began treating patients with the GammaPod™ Stereotactic Radiotherapy System, a breast cancer treatment...
GammaPod Stereotactic Radiotherapy System for Breast Cancer Receives CE Mark
COLUMBIA, Md., April 25, 2019 /PRNewswire/ -- Xcision Medical Systems, LLC announced that the GammaPod stereotactic radiotherapy system has received CE marking, paving the way for new sales in Europe and offering patients the latest option in noninvasive breast cancer...